PMVP
PMV Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.50
+2.74%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.31
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.34
- EPS estimate
- -$0.39
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +11.1%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $5.00
- PT range
- $5.00 – $5.00
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.39 | -$0.34 | Beat 12.26% | — |
| May 12, 2026 | -$0.41 | -$0.34 | Beat 17.07% | — |
| Mar 6, 2026 | -$0.40 | -$0.34 | Beat 15.00% | — |
| Nov 12, 2025 | -$0.40 | -$0.40 | In line | — |
| Aug 7, 2025 | -$0.39 | -$0.41 | Miss -5.13% | — |
| May 9, 2025 | -$0.37 | -$0.34 | Beat 8.11% | — |
| Mar 3, 2025 | -$0.38 | -$0.45 | Miss -18.42% | — |
| Nov 7, 2024 | -$0.35 | -$0.37 | Miss -5.71% | — |
| Aug 8, 2024 | -$0.34 | -$0.02 | Beat 94.12% | — |
| May 9, 2024 | -$0.35 | -$0.30 | Beat 14.29% | — |
| Feb 29, 2024 | -$0.39 | -$0.31 | Beat 20.51% | — |
| Nov 9, 2023 | -$0.45 | -$0.34 | Beat 24.44% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026